Unitedhealth Group Inc UNH
We take great care to ensure that the data presented and summarized in this overview for UNITEDHEALTH GROUP INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding UNH
View all-
Vanguard Group Inc Valley Forge, PA83.9MShares$50.2 Billion0.84% of portfolio
-
Black Rock Inc. New York, NY73.4MShares$43.9 Billion0.86% of portfolio
-
State Street Corp Boston, MA45MShares$26.9 Billion1.02% of portfolio
-
Capital World Investors Los Angeles, CA28MShares$16.8 Billion2.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD26MShares$15.6 Billion1.59% of portfolio
-
Wellington Management Group LLP Boston, MA25.9MShares$15.5 Billion2.4% of portfolio
-
Jpmorgan Chase & CO New York, NY24.3MShares$14.6 Billion1.09% of portfolio
-
Morgan Stanley New York, NY20.1MShares$12 Billion0.8% of portfolio
-
Geode Capital Management, LLC Boston, MA19.3MShares$11.6 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.6MShares$10.5 Billion2.02% of portfolio
Latest Institutional Activity in UNH
Top Purchases
Top Sells
About UNH
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Insider Transactions at UNH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 01
2024
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+2.68%
|
-
|
Oct 01
2024
|
Gil Kristen Director |
BUY
Grant, award, or other acquisition
|
Direct |
151
+5.77%
|
-
|
Oct 01
2024
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
164
+1.23%
|
-
|
Oct 01
2024
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
245
+0.03%
|
-
|
Oct 01
2024
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
151
+3.49%
|
-
|
Oct 01
2024
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
97
+0.24%
|
-
|
Oct 01
2024
|
Charles D. Baker Director |
BUY
Grant, award, or other acquisition
|
Direct |
151
+19.53%
|
-
|
Oct 01
2024
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+1.56%
|
-
|
Oct 01
2024
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+2.92%
|
-
|
Sep 24
2024
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.27%
|
-
|
Sep 24
2024
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.35%
|
-
|
Sep 24
2024
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.31%
|
-
|
Sep 24
2024
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.05%
|
-
|
Sep 24
2024
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
95
+0.1%
|
-
|
Sep 24
2024
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
38
+0.12%
|
-
|
Sep 24
2024
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.36%
|
-
|
Sep 24
2024
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.0%
|
-
|
Sep 24
2024
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
66
+0.04%
|
-
|
Sep 24
2024
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.25%
|
-
|
Sep 24
2024
|
Gil Kristen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.27%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 107K shares |
---|---|
Exercise of conversion of derivative security | 607K shares |
Payment of exercise price or tax liability | 324K shares |
---|---|
Bona fide gift | 102K shares |
Open market or private sale | 227K shares |